Work

Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors

Year: 2011

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-011-1724-7

Authors: Elaine T. Lam, Sanjay Goel, Larry J. Schaaf, Gillian F. Cropp, Alison L. Hannah, Yiqing Zhou, Barbara McCracken, Brandi I. Haley, Robert G. Johnson, Sridhar Mani, Miguel A. Villalona-Calero

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, Kosan Biosciences (United States), The Ohio State University

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Ohio State University, National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2054701310

FWCI: 0.944

Cites: 32

Cited by: 18

Related to: 10